Tap Consulting, LLC Opiant Pharmaceuticals, Inc. Transaction History

Tap Consulting, LLC

  • $487 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$19.54 - $33.59 $9,203 - $15,820
-471 Closed
0 $0
Q4 2021

Jan 27, 2022
BUY
$22.51 - $36.79 $10,602 - $17,328
471 New
471 $16,000

Others Institutions Holding OPNT

# of Institutions
2
Shares Held
300
Call Options Held
0
Put Options Held
0
View Full List

About OPIANT PHARMACEUTICALS, INC.

OPNT Quotes by TradingView
  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Tap Consulting, LLC Portfolio

Follow Tap Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email